Epsilon M&A Deal Report - MedCore
Transaction Multiples for the Valuation of Private Companies
Karo Bio / MedCore
No EMAT :
75827
Announced Date :
28/10/2015
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Karo Bio
Target :
MedCore
Country :
Sweden
Sector of activity :
- Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Supplies
Business Description :
Founded in 2000, MedCore sells and markets AN/IVA, diabetes, surgery, and respiration products in the Nordic market. > Markets primarily licensed medtech products to pharmacies and hospitals in the...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
ns | ns | ns | ns | ns | ||
| Current |
|
ns |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Supplies » = 73
| Date | Acquirer | Target | Country | Multiples | See details |
| 28/02/2013 | Omega Pharma | Arterin | Belgium | ** | 75812 |
| 18/11/2015 | Charles River Laboratories International | Oncotest | Germany | *** | 75789 |
Source: Epsilon Research / EMAT
